High frequency of co-infection by Epstein-Barr virus types 1 and 2 in patients with multiple sclerosis

Mult Scler. 2011 Nov;17(11):1295-300. doi: 10.1177/1352458511411063. Epub 2011 Jul 14.

Abstract

Background: The existence of Epstein-Barr virus (EBV) strains specifically associated with multiple sclerosis (MS) is a matter of controversy. Little is also known about the prevalence of EBV types 1 and 2 in MS patients and the presence of co-infections by both strains.

Objective: To make EBV strain type assignment and compare the frequencies of types 1, 2 and co-infections by both in MS patients and healthy controls.

Methods: Blood samples from 75 consecutive MS patients and 186 controls were collected. EBV was simultaneously detected and typed using a polymerase chain reaction (PCR) which amplified a strain-specific sequence in the EBV nuclear antigen 2.

Results: EBV was detected in 70 out of 75 patients (93.3%) and in 123 of 186 controls (66.1%). Among positive cases, type 1 was found in 6 patients (8.6%) and 40 controls (32.5%), type 2 in 1 patient (1.4%) and 37 controls (30.1%), and dual-infections by both EBV types were detected in 63 patients (90%) and 46 controls (37.4%). Logistic regression models showed that MS was significantly associated with the presence of EBV (p < 0.001) and also with dual type infections (p < 0.001).

Conclusion: This study provides molecular evidence associating co-infection of type 1 and 2 EBV with MS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Case-Control Studies
  • Chi-Square Distribution
  • Coinfection*
  • DNA, Viral / blood
  • Epstein-Barr Virus Infections / diagnosis
  • Epstein-Barr Virus Infections / epidemiology*
  • Epstein-Barr Virus Infections / virology*
  • Epstein-Barr Virus Nuclear Antigens / genetics
  • Female
  • Herpesvirus 4, Human / classification*
  • Herpesvirus 4, Human / genetics
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Multiple Sclerosis / diagnosis
  • Multiple Sclerosis / epidemiology*
  • Multiple Sclerosis / virology*
  • Odds Ratio
  • Polymerase Chain Reaction
  • Risk Assessment
  • Risk Factors
  • Spain / epidemiology
  • Viral Proteins / genetics
  • Young Adult

Substances

  • DNA, Viral
  • EBNA-2 protein, Human herpesvirus 4
  • Epstein-Barr Virus Nuclear Antigens
  • Viral Proteins